Everything below concerns synaptogenesis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.
Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
=== US rationale === The Trump administration did not initially announce any specific legal authority for the first strike. Secretary of Defense Pete Hegseth declared, "We have the absolute and complete authority", citing "... the defense of the American people alone. 100,000 Americans were killed each year under the previous administration because of an open border and open drug traffic flow. That is an assault on the American people." Regarding the initial strike, the Trump administration did not provide evidence about the vessel's cargo, nor did it establish that the vessel's crew were threatening to attack. Trump was questioned on 5 September about the legality of the first strike, to which he responded: "We don't want drugs killing our people. I believe we lost 300,000 ... last year"—a number he repeated days later in an Oval Office meeting. Drug overdose deaths in the US in 2024 were about 80,000 according to the US Centers for Disease Control and Prevention, representing a 25 percent decline from the previous year deaths of 112,910. When speaking impromptu to reporters prior to boarding Air Force One on 14 September, Trump inflated that number to 300 million. CNN states that "allegations involving [Venezuela's] presidential palace in cocaine trafficking have existed for at least a decade." Former US Attorney General William Barr first accused Maduro of supporting drug trafficking in 2020, stating that 250 tons of cocaine are smuggled through Venezuela annually, facilitated by the government, although no evidence was presented.
== External links == What's in an Oil Drop? An Introduction to Fourier Transform Ion Cyclotron Resonance (FT-ICR) for Non-scientists National High Magnetic Field Laboratory Scottish Instrumentation Resource Centre for Advanced Mass Spectrometry Fourier-transform Ion Cyclotron Resonance (FT-ICR) FT-ICR Introduction University of Bristol
The unattended and remote nature of many data logger applications implies the need for some applications to operate from a DC power source, such as a battery. Solar power may be used to supplement these power sources. These constraints have generally led to ensuring that the devices they market are extremely power efficient relative to computers. In many cases, they are required to operate in harsh environmental conditions where computers will not function reliably. This unattended nature also dictates that data loggers must be extremely reliable. Since they may operate for long periods nonstop with little or no human supervision and may be installed in harsh or remote locations, it is imperative that so long as they have power, they will not fail to log data for any reason. Manufacturers go to great lengths to ensure that the devices can be depended on in these applications. As such data loggers are almost completely immune to the problems that might affect a general-purpose computer in the same application, such as program crashes and the instability of some operating systems.
Sources: en.wikipedia.org
After structural comparison with different species of Penicillium, Fleming believed that his specimen was Penicillium chrysogenum, a species described by an American microbiologist Charles Thom in 1910. Charles John Patrick La Touche, an Irish botanist, had recently joined St Mary's as a mycologist, and he identified the specimen as Penicillium rubrum, the identification used by Fleming in his publication. In 1931, Thom re-examined different Penicillia, including that of Fleming's specimen, and he came to the conclusion that Fleming's specimen was P. notatum, a member of the P. chrysogenum series. From then on, Fleming's mould was synonymously referred to as P. notatum and P. chrysogenum. To resolve the confusion, the Seventeenth International Botanical Congress held in Vienna, Austria, in 2005 formally adopted P. chrysogenum as the name. Whole-genome sequence and phylogenetic analysis in 2011 revealed that Fleming's mould belongs to P. rubens, a species described by Belgian microbiologist Philibert Biourge in 1923. The source of the fungal contamination in Fleming's experiment remained the subject of speculation for several decades. Fleming suggested in 1945 that the fungal spores came through the window facing Praed Street, but was disputed by his co-workers, who testified much later that Fleming's laboratory window was kept shut, and Fleming was unable to reach the window to open it. A consensus developed that the mould had come from La Touche's laboratory, a floor below Fleming's, and that spores had drifted in through the open doors.
At the highest trophic level is typically an apex predator, a consumer with no natural predators in the food chain model. When any trophic level dies, detritivores and decomposers consume their organic material for energy and expel nutrients into the environment in their waste. Decomposers and detritivores break down the organic compounds into simple nutrients that are returned to the soil. These are the simple nutrients that plants require to create organic compounds. It is estimated that there are more than 100,000 different decomposers in existence. Models of trophic levels also often model energy transfer between trophic levels. Primary consumers get energy from the producer and pass it to the secondary and tertiary consumers.
Its floral axes, or flower-bearing structures, bear bracteoles, or specialised leaves, that sprout from the flower stems; the latter are known as pedicels. After aestivating in spring, the plant sends up its true leaves, each up to 40 cm (16 in) in length. Only in October, after most other flowering plants have released their seeds, do its brilliantly hued flowers develop; they range from a light pastel shade of lilac to a darker and more striated mauve. The flowers possess a sweet, honey-like fragrance. Upon flowering, the plants are 20–30 cm (8–12 in) in height and bear up to four flowers. A three-pronged style 25–30 mm (1–1+3⁄16 in) in length, emerges from each flower. Each prong terminates with a vivid crimson stigma, which is the distal end of a carpel.
Lee Waise Lee as Edward Lai (黎永廉), Secretary of Justice / co-conspirator of Peter Choi King Kong Lam as Gary Fu, Ex-Senior Inspector of Police Vincent Lam as Neo Chan, Ex-Senior Inspector of Police Wong Man-piu as Eric Ma, Ex-Senior Inspector of Police Brian Wong as Mark Cheng, Ex-Senior Inspector of Police Felix Lok as C.Y. Ma, Member of the Legislative Council / Chairman of Security Panel Council / co-conspirator of Peter Choi Terence Yin as To Man, Chief Superintendent, Director of Information Technology Jeannie Chan as Nicole Chan, ICAC Assistant Investigator Kathy Yuen as Cecilia Lai, Probationary Inspector of Police and secretary to Commissioner Dexter Young as Senior Inspector of Police, Technology Crime Division Queenie Chu as Amber Tsui, cigar lounge owner / co-conspirator of Peter Choi Leila Tong as Karen Tang, hostage
Sources: en.wikipedia.org
== External links == Attorney General Ellison files lawsuit against COVID-19 testing sites, lab for deceiving consumers, Minnesota Attorney General, January 19, 2022 Complaint in State of Minnesota, by its Attorney General, Keith Ellison v. Center for COVID Control, LLC and Doctors Clinical Laboratory, Inc., filed in Hennepin County District Court on January 19, 2022, file # 27-CV-22-731
== Golf scandals == Jane Blalock cheating controversy – one of the LPGA Tour's top players, Jane Blalock, was accused of illegally marking her golf ball on the green. She was suspended and fined by the tour, but Blalock in turn filed suit and won an injunction that allowed her to continue playing. Blalock eventually won her lawsuit and she and the LPGA reached an out-of-court settlement. Vijay Singh, a former number one golfer in the world, was suspended from the PGA Tour for using deer antler spray, which violated the PGA Tour Anti-Doping Policy. Likewise in 1985, Vijay Singh was caught erasing his score on a hole and replacing it with a lower score after the scorecard had been signed. Once the rules officials confirmed the allegations, Singh was banned from the Asian Tour. To this day, Singh has not acknowledged that he cheated.
== Lead optimization phase == The objective of this drug discovery phase is to synthesize lead compounds, new analogs with improved potency, reduced off-target activities, and physiochemical/metabolic properties suggestive of reasonable in vivo pharmacokinetics. This optimization is accomplished through chemical modification of the hit structure, with modifications chosen by employing knowledge of the structure–activity relationship (SAR) as well as structure-based design if structural information about the target is available. Lead optimization is concerned with experimental testing and confirmation of the compound based on animal efficacy models and ADMET (in vitro and in situ) tools that may be followed by target identification and target validation.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.